Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease
Liver International · 2025-05 · 45 (5)
DOI: 10.1111/liv.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 08.04.2025. Verfasst von Camilla Lorenzen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration, Copper. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anna Soria received support by a Río Hortega grant and Instituto de Salud Carlos III (ISCIII), Accion Estrategica en Salud (expedient CM23/00133)., CERCA Programme/Generalitat de Catalunya, European Union (expedient CM23/00133), Instituto de Salud Carlos III, Acción Estratégica en Salud, December 2023 Call (A.S.C).
Abstract (Originalsprache)
Background and Aims Diagnosing Wilson disease (WD) remains challenging. The exchangeable copper (CuEXC) methodology measures the non‐ceruloplasmin‐bound copper fraction in serum. Relative exchangeable copper (REC), the ratio of CuEXC to total serum copper (Total Cu), has been proposed as a potential diagnostic biomarker. This study aimed to evaluate the diagnostic performance of these three copper biomarkers in WD.
Methods
CuEXC and Total Cu levels were measured in newly diagnosed treatment‐naïve patients with WD ( n = 13), treated WD ( n = 91), non‐Wilsonian hepatic disease ( n = 206) and non‐Wilsonian acute liver failure ( n = 22). REC, CuEXC and Total Cu were compared among groups. Receiver‐operating characteristic analyses were performed.
Results
Median REC was significantly elevated among patients with WD compared to all other groups combined (23.6% vs. 4.9%, p < 0.001). The opposite was found for Total Cu (3.5 μmol/L vs. 17.2 μmol/L, p < 0.001). In newly diagnosed patients with WD, median REC was significantly higher than in treated patients (29.1% vs. 21.6%, p = 0.008). The optimal diagnostic cut‐off value for REC was ≥ 13.8% (sensitivity 100% and specificity 99.6%) for newly diagnosed patients versus those with non‐Wilsonian hepatic disease. For Total Cu, the optimal cut‐off was ≤ 7.1 μmol/L (sensitivity 61.5% and specificity 99.1%) for newly diagnosed patients with WD versus those with non‐Wilsonian hepatic disease.
Conclusion
Our data support the diagnostic value of REC in WD. The more broadly available Total Cu also demonstrates a strong diagnostic performance and may be useful in initial work‐up. We suggest including REC and/or Total Cu in a future revision of the Leipzig score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Liver Unit, Hospital Clínic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red, Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
- European Reference Network on Rare Hepatological Diseases (ERN RARE-Liver), Hamburg, Germany.
- Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
- Department of Intestinal Failure and Liver Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Camilla Lorenzen, Xavier Forns, Frederik Teicher Kirk, Anna Soria, Sergio Rodríguez-Tajes, Zoe Mariño
Förderung
- Anna Soria received support by a Río Hortega grant and Instituto de Salud Carlos III (ISCIII), Accion Estrategica en Salud (expedient CM23/00133).
- CERCA Programme/Generalitat de Catalunya
- European Union (expedient CM23/00133), Instituto de Salud Carlos III, Acción Estratégica en Salud, December 2023 Call (A.S.C)
- Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (Grant 2021_SGR_01322)
- Fabrikant Vilhelm Pedersen og Hustrus Legat
- Instituto de Salud Carlos III
- Generalitat de Catalunya
- European Commission
Zitieren
APA
Lorenzen, C., Dons, K., García-Solà, C., Forns, X., Kirk, F. T., Lynderup, E. M., Rewitz, K. S., Soria, A., Rodríguez-Tajes, S., Christensen, L. D., Gyldenholm, T., Bjerring, P. N., Miralpeix, A., Torra, M., Ott, P., Sandahl, T. D., & Mariño, Z. (2025). Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease. Liver International, 45(5). https://doi.org/10.1111/liv.70089
Vancouver
Lorenzen C, Dons K, García-Solà C, Forns X, Kirk FT, Lynderup EM, et al. Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease. Liver International. 2025;45(5). doi:10.1111/liv.70089
BibTeX
@article{Lorenzen2025,
author = {Lorenzen, Camilla and Dons, Karen and García-Solà, Clàudia and Forns, Xavier and Kirk, Frederik Teicher and Lynderup, Emilie Munk and Rewitz, Karina Stubkjær and Soria, Anna and Rodríguez-Tajes, Sergio and Christensen, Lene Damm and Gyldenholm, Tua and Bjerring, Peter Nissen and Miralpeix, Anna and Torra, Mercè and Ott, Peter and Sandahl, Thomas Damgaard and Mariño, Zoe},
title = {Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease},
journal = {Liver International},
year = {2025},
volume = {45},
number = {5},
doi = {10.1111/liv.70089}
}
EUVIMED